Showing 31,261 - 31,280 results of 105,386 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.09s Refine Results
  1. 31261
  2. 31262
  3. 31263
  4. 31264
  5. 31265
  6. 31266
  7. 31267
  8. 31268
  9. 31269

    Image_1_Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase.TIF by Ao Hu (623701)

    Published 2020
    “…The mechanism of action study revealed that anthralin inhibits the cap-binding function of PB2 subunit and endonuclease activity of PA. As a result, viral mRNA transcription is blocked, leading to the decreases in viral RNA replication and viral protein expression. …”
  10. 31270

    Image_2_Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase.TIF by Ao Hu (623701)

    Published 2020
    “…The mechanism of action study revealed that anthralin inhibits the cap-binding function of PB2 subunit and endonuclease activity of PA. As a result, viral mRNA transcription is blocked, leading to the decreases in viral RNA replication and viral protein expression. …”
  11. 31271

    Genetic resistance to DEHP-induced transgenerational endocrine disruption by Ludwig Stenz (779897)

    Published 2019
    “…A DEHP-susceptibility allele in C57BL/6J contained five SNPs (rs28279710, rs32977910, rs46648903, rs46677594 and rs48287999) affecting SHP and six genes (<i>Svs2</i>, <i>Svs3b</i>, <i>Svs4</i>, <i>Svs3a</i>, <i>Svs6</i> and <i>Svs5)</i> epigenetically silenced by DEHP. …”
  12. 31272
  13. 31273
  14. 31274
  15. 31275
  16. 31276
  17. 31277
  18. 31278

    Supplementary file 1_Persistent neurocognitive abnormalities as clinical sequelae of mild to moderate COVID-19.docx by Agnieszka Bednarska (4061083)

    Published 2025
    “…Seroconversion to anti-SARS-CoV-2 IgG was detected in 49 (87.5%) out of 56 patients tested and was more common among those with a more severe course of the infection.…”
  19. 31279

    DataSheet1_The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.docx by Nanyong Gao (12220706)

    Published 2022
    “…The results demonstrated that the relative clearance rates of CYP3A4.19, 10, 18, 5, 16, 14, 11, 2, 13, 12, 7, 8, and 17 in catalyzing osimertinib were significantly reduced to a minimum of 25.68% compared to CYP3A4.1, while those of CYP3A4.29, 32, 33, 28, 15, 34, and 3 were obviously enhanced, ranging from 114.14% to 284.52%. …”
  20. 31280